Live Breaking News & Updates on Insider Activity At Madrigal Pharmaceuticals

Stay updated with breaking news from Insider activity at madrigal pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Madrigal Pharmaceuticals (NASDAQ:MDGL) Issues Quarterly Earnings Results, Misses Estimates By $1.32 EPS

Madrigal Pharmaceuticals (NASDAQ:MDGL) Issues Quarterly Earnings Results, Misses Estimates By $1.32 EPS
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

United States , Richards Levy , Piper Sandler , Paula Friedman , Madrigal Pharmaceuticals Stock Down , Canaccord Genuity Group , Madrigal Pharmaceuticals , Madrigal Pharmaceuticals Company Profile , News Ratings For Madrigal Pharmaceuticals Daily , Madrigal Pharmaceuticals Inc , Securities Exchange Commission , Insider Activity At Madrigal Pharmaceuticals , Earnings History For Madrigal Pharmaceuticals , Get Free Report , Pharmaceuticals Stock Down , Director Paul , Director Richard , Exchange Commission , Madrigal Pharmaceuticals Daily ,

HC Wainwright Lowers Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target to $390.00

HC Wainwright Lowers Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target to $390.00
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United States , Jamesm Daly , Rebecca Taub , Piper Sandler , Principal Financial Group Inc , Dana Investment Advisors Inc , Global Retirement Partners , Madrigal Pharmaceuticals Stock Performance , Securities Exchange Commission , Columbus Asset Advisors , Madrigal Pharmaceuticals , News Ratings For Madrigal Pharmaceuticals Daily , Madrigal Pharmaceuticals Inc , Analyst Recommendations For Madrigal Pharmaceuticals , Institutional Investors Weigh In On Madrigal Pharmaceuticals , Insider Activity At Madrigal Pharmaceuticals , Get Free Report , Exchange Commission , Director James , Retirement Partners , Investment Advisors , Principal Financial Group , Financial Group , Madrigal Pharmaceuticals Daily ,

Madrigal Pharmaceuticals (MDGL) Scheduled to Post Quarterly Earnings on Tuesday

Madrigal Pharmaceuticals (NASDAQ:MDGL – Get Free Report) is scheduled to post its quarterly earnings results before the market opens on Tuesday, May 7th. Analysts expect Madrigal Pharmaceuticals to post earnings of ($6.06) per share for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link. Madrigal Pharmaceuticals […] ....

United States , Jamesm Daly , Piper Sandler , Richards Levy , Earnings History For Madrigal Pharmaceuticals , Madrigal Pharmaceuticals Stock Performance , Madrigal Pharmaceuticals Company Profile , Madrigal Pharmaceuticals , News Ratings For Madrigal Pharmaceuticals Daily , Insider Activity At Madrigal Pharmaceuticals , Madrigal Pharmaceuticals Inc , Get Free Report , Director James , Director Richard , Madrigal Pharmaceuticals Daily , Nasdaq Mdgl ,

Connor Clark & Lunn Investment Management Ltd. Has $7.55 Million Stock Holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)

Connor Clark & Lunn Investment Management Ltd. lowered its holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) by 21.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 51,686 shares of the biopharmaceutical company’s stock after selling 14,075 shares during the […] ....

United States , Roberte Waltermire , Brian Joseph Lynch , Piper Sandler , Madrigal Pharmaceuticals Inc , Connor Clark Lunn Investment Management Ltd , Blackrock Inc , Madrigal Pharmaceuticals Price Performance , Madrigal Pharmaceuticals Company Profile , Quarter For Madrigal Pharmaceuticals , News Ratings For Madrigal Pharmaceuticals Daily , Perceptive Advisors , Insider Activity At Madrigal Pharmaceuticals , Vanguard Group Inc , Exchange Commission , Securities Exchange Commission , Madrigal Pharmaceuticals , Connor Clark , Lunn Investment Management , Free Report , Street Corp , Joseph Lynch , Madrigal Pharmaceuticals Daily , Nasdaq Mdgl , Sec Filings , Hedge Fund Holdings ,

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Given Consensus Rating of "Moderate Buy" by Analysts

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report) has earned an average rating of “Moderate Buy” from the seven research firms that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and six have issued a buy rating on the company. The average 1-year price objective […] ....

United States , Piper Sandler , Brian Joseph Lynch , York Mellon Corp , Madrigal Pharmaceuticals Stock Down , Madrigal Pharmaceuticals Inc , Analyst Recommendations For Madrigal Pharmaceuticals , Boxer Capital , Wintrust Investments , Deutsche Bank , Insider Activity At Madrigal Pharmaceuticals , Securities Exchange Commission , Madrigal Pharmaceuticals , News Ratings For Madrigal Pharmaceuticals Daily , Jp Morgan Private Wealth Advisors , Get Free Report , Marketbeat Ratings , Joseph Lynch , Exchange Commission , Advisors Lp Baker , New York Mellon Corp , Private Wealth Advisors , Pharmaceuticals Stock Down , Get Free , Madrigal Pharmaceuticals Daily , Nasdaq Mdgl ,